Richard Brand, Chief Financial Officer, DiaCarta discusses precision molecular diagnostics that are being used for early detection of cancer. By using liquid biopsy technology, blood draw can be used for early detection and monitoring of people who have cancer and avoiding the need for a physical biopsy. Also a radiation therapy and chemotherapy tests are supporting personalized medicine for those undergoing treatment who are at the extreme tails of the population - either very sensitive to it or have a very robust response - so as to better determine appropriate dosage.
@DiaCarta_DX #DiaCarta #liquidbiopsy #earlycancerdetection #precisionmedicine #personalizedmedicine #coloncancer
DiaCarta.com
Download the transcript here
Empowered Patient Podcast